301126 达嘉维康
已收盘 05-22 15:00:00
资讯
新帖
简况
达嘉维康（301126）披露2025年年度股东会决议公告，5月20日股价下跌1.27%
证券之星 · 05-20 18:35
达嘉维康（301126）披露2025年年度股东会决议公告，5月20日股价下跌1.27%
股市必读：达嘉维康（301126）5月13日董秘有最新回复
证券之星 · 05-14
股市必读：达嘉维康（301126）5月13日董秘有最新回复
股市必读：达嘉维康(301126)股东户数1.44万户，较上期减少6.4%
证券之星 · 05-11
股市必读：达嘉维康(301126)股东户数1.44万户，较上期减少6.4%
达嘉维康（301126）披露2023年限制性股票与股票期权激励计划部分股票期权注销完成公告，5月8日股价上涨1.77%
证券之星 · 05-08
达嘉维康（301126）披露2023年限制性股票与股票期权激励计划部分股票期权注销完成公告，5月8日股价上涨1.77%
达嘉维康（301126）披露举办2025年度暨2026年第一季度网上业绩说明会公告，5月7日股价下跌1.16%
证券之星 · 05-07
达嘉维康（301126）披露举办2025年度暨2026年第一季度网上业绩说明会公告，5月7日股价下跌1.16%
达嘉维康（301126）披露关于2023年限制性股票与股票期权激励计划作废部分第二类限制性股票及注销部分股票期权的公告，4月28日股价上涨2.72%
证券之星 · 04-28
达嘉维康（301126）披露关于2023年限制性股票与股票期权激励计划作废部分第二类限制性股票及注销部分股票期权的公告，4月28日股价上涨2.72%
图解达嘉维康年报：第四季度单季净利润同比下降2406.77%
证券之星 · 04-28
图解达嘉维康年报：第四季度单季净利润同比下降2406.77%
达嘉维康（301126）披露对外担保进展公告，4月7日股价上涨2.06%
证券之星 · 04-07
达嘉维康（301126）披露对外担保进展公告，4月7日股价上涨2.06%
达嘉维康（301126）披露对外担保进展公告，3月27日股价上涨3.18%
证券之星 · 03-27
达嘉维康（301126）披露对外担保进展公告，3月27日股价上涨3.18%
达嘉维康（301126）披露对外担保进展公告，3月20日股价下跌3.68%
证券之星 · 03-20
达嘉维康（301126）披露对外担保进展公告，3月20日股价下跌3.68%
达嘉维康（301126）披露对外担保进展公告，3月12日股价下跌1.71%
证券之星 · 03-12
达嘉维康（301126）披露对外担保进展公告，3月12日股价下跌1.71%
达嘉维康最新公告：实控人之一致行动人拟减持公司不超3%股份
证券之星 · 02-06
达嘉维康最新公告：实控人之一致行动人拟减持公司不超3%股份
达嘉维康股东拟减持不超过3%股份 减持窗口期为3月10日至6月9日
美股速递 · 02-06
达嘉维康股东拟减持不超过3%股份 减持窗口期为3月10日至6月9日
达嘉维康(301126.SZ)发预亏，预计2025年度归母净亏损2.5亿元至3亿元
智通财经 · 01-26
达嘉维康(301126.SZ)发预亏，预计2025年度归母净亏损2.5亿元至3亿元
达嘉维康：预计2025年全年营业收入55亿元至60亿元
证券之星 · 01-26
达嘉维康：预计2025年全年营业收入55亿元至60亿元
股市必读：达嘉维康（301126）1月22日董秘有最新回复
证券之星 · 01-23
股市必读：达嘉维康（301126）1月22日董秘有最新回复
达嘉维康：统一股东人数信息披露口径
证券之星 · 01-21
达嘉维康：统一股东人数信息披露口径
达嘉维康：积极推进AI技术促进业务发展
证券之星 · 01-13
达嘉维康：积极推进AI技术促进业务发展
达嘉维康：公司截至2025年12月31日股东人数为16,103人
证券之星 · 01-07
达嘉维康：公司截至2025年12月31日股东人数为16,103人
每周股票复盘：达嘉维康（301126）募投项目节余251.99万元补流
证券之星 · 01-03
每周股票复盘：达嘉维康（301126）募投项目节余251.99万元补流
加载更多
公司概况
公司名称：
湖南达嘉维康医药产业股份有限公司
所属行业：
批发业
上市日期：
2021-12-07
主营业务：
湖南达嘉维康医药产业股份有限公司的主营业务是药品、生物制品、医疗器械等产品的分销及零售业务。公司的主要产品是小建中颗粒、五味安神颗粒、九味肝泰胶囊、小儿咽扁颗粒、新生化颗粒、阿奇霉素颗粒。公司子公司达嘉医药是国家4A级医药物流企业、湖南省医药储备企业、湖南省常态短缺药品承储企业。
发行价格：
12.37
{"stockData":{"symbol":"301126","market":"SZ","secType":"STK","nameCN":"达嘉维康","latestPrice":11.37,"timestamp":1779433407000,"preClose":11.17,"halted":0,"volume":3591011,"delay":0,"changeRate":0.0179,"floatShares":138000000,"shares":204999999,"eps":-1.1667,"marketStatus":"已收盘","change":0.2,"latestTime":"05-22 15:00:00","open":11.2,"high":11.46,"low":11.01,"amount":40346500,"amplitude":0.0403,"askPrice":11.37,"askSize":160,"bidPrice":11.33,"bidSize":7,"shortable":0,"etf":0,"ttmEps":-1.1667,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779672600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.17,"symbolType":"stock","openAndCloseTimeList":[[1779413400000,1779420600000],[1779426000000,1779433200000]],"highLimit":12.29,"lowLimit":10.05,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":205403200,"isCdr":false,"pbRate":1.53,"roa":"--","roe":"0.4%","epsLYR":-1.18,"committee":-0.30038,"marketValue":2335000000,"turnoverRate":0.026,"status":0,"floatMarketCap":1568000000},"requestUrl":"/m/hq/s/301126","defaultTab":"news","newsList":[{"id":"2636184659","title":"达嘉维康（301126）披露2025年年度股东会决议公告，5月20日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636184659","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636184659?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:35","pubTimestamp":1779273317,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，达嘉维康报收于11.67元，较前一交易日下跌1.27%，最新总市值为23.97亿元。该股当日开盘11.86元，最高11.86元，最低11.5元，成交额达3351.82万元，换手率为2.09%。公司于近日披露《2025年年度股东会决议公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000035896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635537637","title":"股市必读：达嘉维康（301126）5月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2635537637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635537637?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:22","pubTimestamp":1778703732,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，达嘉维康报收于11.93元，下跌1.08%，换手率1.65%，成交量2.27万手，成交额2715.21万元。董秘最新回复投资者： 请问截至2026年5月10日公司的股东总数是多少？交易信息汇总资金流向5月13日主力资金净流出96.52万元；游资资金净流入145.61万元；散户资金净流出49.09万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400004657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634429456","title":"股市必读：达嘉维康(301126)股东户数1.44万户，较上期减少6.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634429456","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634429456?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:14","pubTimestamp":1778444054,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，达嘉维康报收于12.1元，上涨1.77%，换手率2.6%，成交量3.58万手，成交额4318.72万元。股本股东变化股东户数变动近日达嘉维康披露，截至2026年4月30日公司股东户数为1.44万户，较3月31日减少985.0户，减幅为6.4%。公司公告汇总关于2023年限制性股票与股票期权激励计划部分股票期权注销完成的公告湖南达嘉维康医药产业股份有限公司于2026年4月24日召开董事会，审议通过作废部分第二类限制性股票及注销部分股票期权的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633786432","title":"达嘉维康（301126）披露2023年限制性股票与股票期权激励计划部分股票期权注销完成公告，5月8日股价上涨1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633786432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633786432?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:19","pubTimestamp":1778235544,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，达嘉维康报收于12.1元，较前一交易日上涨1.77%，最新总市值为24.85亿元。公司于2026年5月8日发布《关于2023年限制性股票与股票期权激励计划部分股票期权注销完成的公告》。公告显示，湖南达嘉维康医药产业股份有限公司于2026年4月24日召开董事会，审议通过作废部分第二类限制性股票及注销部分股票期权的议案。该事项已于2026年5月8日经中国证券登记结算有限责任公司深圳分公司审核确认完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800035163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633114277","title":"达嘉维康（301126）披露举办2025年度暨2026年第一季度网上业绩说明会公告，5月7日股价下跌1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633114277","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633114277?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:46","pubTimestamp":1778147217,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，达嘉维康报收于11.89元，较前一交易日下跌1.16%，最新总市值为24.42亿元。该股当日开盘12.03元，最高12.17元，最低11.85元，成交额达5390.38万元，换手率为3.26%。近日，达嘉维康发布《关于举办2025年度暨2026年第一季度网上业绩说明会的公告》。投资者可于2026年5月15日前通过指定网址或微信小程序提交问题。公司董事、总经理、财务总监胡胜利，独立董事汪志刚，董事、董事会秘书蒋茜将出席。会后可通过价值在线或易董app查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700029827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630530548","title":"达嘉维康（301126）披露关于2023年限制性股票与股票期权激励计划作废部分第二类限制性股票及注销部分股票期权的公告，4月28日股价上涨2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630530548","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630530548?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:15","pubTimestamp":1777374938,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，达嘉维康报收于11.69元，较前一交易日上涨2.72%，最新总市值为24.01亿元。公告显示，湖南达嘉维康医药产业股份有限公司于2026年4月24日召开董事会，审议通过作废部分第二类限制性股票及注销部分股票期权的议案。因3名激励对象离职，作废尚未归属的第二类限制性股票5.4万股，注销尚未行权的股票期权12.6万份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800055100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630319823","title":"图解达嘉维康年报：第四季度单季净利润同比下降2406.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630319823","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630319823?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:00","pubTimestamp":1777309236,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康2025年年报显示，当年度公司主营收入51.44亿元，同比下降1.7%；归母净利润-2.42亿元，同比下降1012.36%；扣非净利润-2.58亿元，同比下降1108.46%；其中2025年第四季度，公司单季度主营收入10.14亿元，同比下降18.88%；单季度归母净利润-2.48亿元，同比下降2406.77%；单季度扣非净利润-2.62亿元，同比下降2592.29%；负债率74.86%，投资收益-37.07万元，财务费用1.17亿元，毛利率18.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800002768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625316899","title":"达嘉维康（301126）披露对外担保进展公告，4月7日股价上涨2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625316899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625316899?lang=zh_cn&edition=full","pubTime":"2026-04-07 18:07","pubTimestamp":1775556433,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，达嘉维康报收于11.42元，较前一交易日上涨2.06%，最新总市值为23.46亿元。该股当日开盘11.21元，最高11.54元，最低10.99元，成交额达6504.61万元，换手率为4.16%。近日，达嘉维康发布《关于对外担保的进展公告》。截至公告日，公司对达嘉医药累计提供担保余额为104,290.84万元，占公司最近一期经审计净资产的59.36%。公司及控股子公司无逾期担保、无对外部单位担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700025094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622738238","title":"达嘉维康（301126）披露对外担保进展公告，3月27日股价上涨3.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622738238","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622738238?lang=zh_cn&edition=full","pubTime":"2026-03-27 22:39","pubTimestamp":1774622357,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，达嘉维康报收于11.35元，较前一交易日上涨3.18%，最新总市值为23.31亿元。该股当日开盘10.94元，最高11.35元，最低10.76元，成交额达4488.47万元，换手率为2.91%。近日，湖南达嘉维康医药产业股份有限公司发布《关于对外担保的进展公告》。上述担保在公司2025年度股东大会审议通过的30亿元担保额度范围内。截至公告日，公司累计担保余额为152,755.91万元，占最近一期经审计净资产的86.95%，均为对合并报表范围内子公司的担保，无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700050435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620198732","title":"达嘉维康（301126）披露对外担保进展公告，3月20日股价下跌3.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620198732","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620198732?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:33","pubTimestamp":1774017196,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，达嘉维康报收于11.25元，较前一交易日下跌3.68%，最新总市值为23.11亿元。湖南达嘉维康医药产业股份有限公司于2026年3月20日发布公告，公司与中国光大银行股份有限公司长沙新华支行签订《最高额保证合同》，为全资子公司达嘉维康生物制药有限公司提供总额1,000万元的连带责任保证担保。截至公告日，公司对达嘉生物累计提供担保余额为4,336.00万元，占公司最近一期经审计净资产的2.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000043788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618130421","title":"达嘉维康（301126）披露对外担保进展公告，3月12日股价下跌1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618130421","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618130421?lang=zh_cn&edition=full","pubTime":"2026-03-12 22:46","pubTimestamp":1773326775,"startTime":"0","endTime":"0","summary":"截至2026年3月12日收盘，达嘉维康报收于12.1元，较前一交易日下跌1.71%，最新总市值为24.85亿元。该股当日开盘12.37元，最高12.39元，最低12.06元，成交额达3925.12万元，换手率为2.34%。公司于2026年3月12日发布《关于对外担保的进展公告》。截至公告日，公司对子公司的担保额度合计30亿元，累计担保余额151,604.70万元，占公司最近一期经审计净资产的86.30%。公司不存在对合并报表外单位担保、逾期担保及诉讼担保事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200039123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609560518","title":"达嘉维康最新公告：实控人之一致行动人拟减持公司不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2609560518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609560518?lang=zh_cn&edition=full","pubTime":"2026-02-06 19:40","pubTimestamp":1770378048,"startTime":"0","endTime":"0","summary":"达嘉维康(301126.SZ)公告称，公司控股股东、实控人之一致行动人长沙同嘉投资管理合伙企业（有限合伙）计划15个交易日后的3个月内，以集中竞价和大宗交易方式，减持公司股份不超过616.21万股（占公司总股本的3%）。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600036069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146187545","title":"达嘉维康股东拟减持不超过3%股份 减持窗口期为3月10日至6月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=1146187545","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146187545?lang=zh_cn&edition=full","pubTime":"2026-02-06 19:31","pubTimestamp":1770377485,"startTime":"0","endTime":"0","summary":"达嘉维康（301126）发布公告称，公司持股5%以上股东计划通过集中竞价或大宗交易方式，在2024年3月10日至6月9日期间减持公司股份不超过总股本的3%。此次减持计划将根据市场情况、公司股价等因素择机实施。减持股东将严格遵守相关法律法规关于减持比例、信息披露等要求。若减持计划实施完毕，该股东持股比例将相应下降，但不会导致公司控制权发生变更。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","301126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606217675","title":"达嘉维康(301126.SZ)发预亏，预计2025年度归母净亏损2.5亿元至3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606217675","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606217675?lang=zh_cn&edition=full","pubTime":"2026-01-26 20:10","pubTimestamp":1769429430,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达嘉维康(301126.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净亏损2.5亿元至3亿元;扣除非经常性损益后的净亏损2.5亿元至3亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"达嘉维康(301126.SZ)发预亏，预计2025年度归母净亏损2.5亿元至3亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606917217","title":"达嘉维康：预计2025年全年营业收入55亿元至60亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606917217","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606917217?lang=zh_cn&edition=full","pubTime":"2026-01-26 20:02","pubTimestamp":1769428975,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康发布业绩预告，预计2025年全年营业收入55亿元至60亿元。达嘉维康2025年三季报显示，前三季度公司主营收入41.3亿元，同比上升3.69%；归母净利润509.74万元，同比下降86.02%；扣非净利润388.18万元，同比下降89.02%；其中2025年第三季度，公司单季度主营收入14.22亿元，同比上升2.79%；单季度归母净利润420.38万元，同比下降8.94%；单季度扣非净利润460.61万元，同比上升8.87%；负债率72.68%，投资收益16.03万元，财务费用8065.47万元，毛利率17.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600031141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605416927","title":"股市必读：达嘉维康（301126）1月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605416927","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605416927?lang=zh_cn&edition=full","pubTime":"2026-01-23 01:30","pubTimestamp":1769103027,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，达嘉维康报收于13.92元，上涨3.11%，换手率11.46%，成交量15.8万手，成交额2.19亿元。董秘最新回复投资者： 请问贵公司截止到一月二十日股东人数是多少？当日关注点来自交易信息汇总：1月22日主力资金净流入1515.96万元，显示主力对个股关注度提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300000781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605174990","title":"达嘉维康：统一股东人数信息披露口径","url":"https://stock-news.laohu8.com/highlight/detail?id=2605174990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605174990?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:36","pubTimestamp":1768984573,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康01月21日在投资者关系平台上答复投资者关心的问题。随着监管机构对信息披露公平性要求不断提升，为确保所有投资者均通过法定渠道同步、公平地获取信息，公司经审慎评估后，统一了此类信息的披露口径。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100026057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603819936","title":"达嘉维康：积极推进AI技术促进业务发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2603819936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603819936?lang=zh_cn&edition=full","pubTime":"2026-01-13 20:53","pubTimestamp":1768308790,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康(301126)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司是否有采用相关AI技术或布局AI应用达嘉维康回复：您好，公司密切关注AI人工智能在医疗领域的应用，积极研究论证新业态与公司现有业务发展的契合度，积极推进落地前沿AI人工智能等创新技术促进公司业务高质量发展。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300039861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601284417","title":"达嘉维康：公司截至2025年12月31日股东人数为16,103人","url":"https://stock-news.laohu8.com/highlight/detail?id=2601284417","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601284417?lang=zh_cn&edition=full","pubTime":"2026-01-07 08:48","pubTimestamp":1767746891,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康(301126)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月31日的股东人数是多少？谢谢达嘉维康回复：您好，公司截至 2025年12月31日股东人数为16,103人。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700005012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600062773","title":"每周股票复盘：达嘉维康（301126）募投项目节余251.99万元补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2600062773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600062773?lang=zh_cn&edition=full","pubTime":"2026-01-03 02:21","pubTimestamp":1767378070,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，达嘉维康报收于12.29元，较上周的13.36元下跌8.01%。本周，达嘉维康12月29日盘中最高价报13.5元。12月30日盘中最低价报11.85元。达嘉维康当前最新总市值25.24亿元，在医药商业板块市值排名32/32，在两市A股市值排名4848/5181。公司公告汇总湖南达嘉维康医药产业股份有限公司首次公开发行股票募投项目已结项，截至2025年12月29日，节余募集资金251.99万元将永久补充流动资金。本次节余金额低于募集资金净额的5%，免于履行董事会审议程序。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779467057569,"stockEarnings":[{"period":"1week","weight":-0.029},{"period":"1month","weight":0.0107},{"period":"3month","weight":-0.0904},{"period":"6month","weight":-0.033},{"period":"1year","weight":0.0745},{"period":"ytd","weight":-0.0749}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0076},{"period":"6month","weight":0.0725},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南达嘉维康医药产业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"14399人(较上一季度减少6.40%)","perCapita":"9574股","listingDate":"2021-12-07","address":"湖南省长沙市岳麓区茯苓路30号","registeredCapital":"20540万元","survey":" 湖南达嘉维康医药产业股份有限公司的主营业务是药品、生物制品、医疗器械等产品的分销及零售业务。公司的主要产品是小建中颗粒、五味安神颗粒、九味肝泰胶囊、小儿咽扁颗粒、新生化颗粒、阿奇霉素颗粒。公司子公司达嘉医药是国家4A级医药物流企业、湖南省医药储备企业、湖南省常态短缺药品承储企业。","listedPrice":12.37},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达嘉维康(301126)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达嘉维康(301126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达嘉维康,301126,达嘉维康股票,达嘉维康股票老虎,达嘉维康股票老虎国际,达嘉维康行情,达嘉维康股票行情,达嘉维康股价,达嘉维康股市,达嘉维康股票价格,达嘉维康股票交易,达嘉维康股票购买,达嘉维康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达嘉维康(301126)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达嘉维康(301126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}